Ranitidine

Breastfeeding
  • TRADE NAMES: Apo-Ranitidine; Axoban; Azantac; Nu-Ranit; Raniben; Raniplex; Ranisen; Sostril; Zantab; Zantac (Concordia); Zantac-C; Zantic
  • INDICATIONS: Duodenal ulcer
  • CLASS: Histamine H2 receptor antagonist
  • HALF-LIFE: 2.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acalabrutinib, Alfentanil, Delavirdine, Fentanyl, Gefitinib, Metformin, Prednisone, Rilpivirine, Risperidone

PREGNANCY CATEGORY: B

Our database has 59 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 11/05/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top